As a tumor suppressor gene, abnormal expression of GNG4 was reported in multiple cancers containing colorectal cancer, bladder cancer, and glioblastoma (Pal et al., 2016; Zhang et al., 2018; Liang L. et al., 2021). Here, GNG4 is linked to colorectal cancer.